Position in PRME
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$104,345
+$3,286 QoQ
Shares Held
28,278
-2.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#105
of 186 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. PRME ranks #101 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in PRME
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,345 | 28,278 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $101,059 | 29,040 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $113,038 | 32,576 | Shares | Sole | 2026-02-10 | |
| 2025-03-31 | $46,794 | 23,515 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $62,946 | 21,557 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $109,733 | 28,355 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $111,332 | 21,660 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $160,160 | 22,880 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $198,198 | 22,370 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $158,516 | 16,616 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||